CareDx Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
John Hanna
Chief executive officer
US$9.6m
Total compensation
| CEO salary percentage | 4.73% |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)
Dec 22CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry
Nov 29
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability
Nov 12CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Sep 19Calculating The Intrinsic Value Of CareDx, Inc (NASDAQ:CDNA)
Aug 27The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 32%
Jul 23Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation?
May 02
AlloMap Testing And OPTN Project Will Expand Markets Despite Risks
CareDx's growth fueled by expanded testing services and strategic investments aims to improve margins and revenue cycle management.CareDx: Some Litigation Clouds Have Cleared
Mar 13Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem
Mar 11CareDx: Too Risky For Me
Dec 30The Market Doesn't Like What It Sees From CareDx, Inc's (NASDAQ:CDNA) Revenues Yet As Shares Tumble 26%
Nov 05CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics
Sep 29CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Aug 01CareDx: Benefiting From Some Certainty
Jul 15Why Investors Shouldn't Be Surprised By CareDx, Inc's (NASDAQ:CDNA) 28% Share Price Plunge
Apr 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 40% But Its Business Prospects Need A Lift Too
Mar 02CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 26% But Its Business Still Trails The Industry
Dec 27CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Dec 27Benign Growth For CareDx, Inc (NASDAQ:CDNA) Underpins Its Share Price
Jun 29Analyst Forecasts Just Became More Bearish On CareDx, Inc (NASDAQ:CDNA)
May 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$70m |
| Jun 30 2025 | n/a | n/a | US$58m |
| Mar 31 2025 | n/a | n/a | US$62m |
| Dec 31 2024 | US$10m | US$454k | US$53m |
Compensation vs Market: John's total compensation ($USD9.61M) is above average for companies of similar size in the US market ($USD3.50M).
Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.
CEO
John Hanna (45 yo)
Mr. John Walter Hanna, Jr. is President, Chief Executive Officer & Director of CareDx, Inc since April 15, 2024. He served as General Manager of Endocrinology, Breast Cancer and Lymphoma at Veracyte, Inc....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.7yrs | US$9.61m | no data | |
| Chief Operating Officer | 1.3yrs | US$4.85m | 0.019% $ 188.1k | |
| General Counsel & Secretary | 2yrs | US$1.28m | 0.19% $ 1.9m | |
| Chief Commercial Officer | 1.3yrs | US$3.68m | 0.016% $ 166.5k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Scientific Officer | 2.3yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Chief Strategy Officer | 1.9yrs | no data | no data | |
| Chief Data & Artificial Intelligence Officer | 1.2yrs | no data | no data | |
| Chief Product Officer | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
Experienced Management: CDNA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.7yrs | US$9.61m | no data | |
| Independent Director | 22.9yrs | US$353.44k | 0.26% $ 2.6m | |
| Independent Chairman | 14.1yrs | US$743.37k | 0.28% $ 2.8m | |
| Independent Director | 6.3yrs | US$372.30k | 0.051% $ 522.4k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 11.7yrs | US$366.06k | 0.26% $ 2.6m | |
| Independent Director | 13.1yrs | US$350.03k | 0.58% $ 5.9m | |
| Independent Director | 1.8yrs | US$552.57k | 0.013% $ 135.1k | |
| Independent Director | 4.3yrs | US$355.04k | 0.052% $ 524.0k | |
| Independent Director | 4.4yrs | US$357.77k | 0.052% $ 530.5k |
Experienced Board: CDNA's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 09:54 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CareDx, Inc is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Massaro | BTIG |
| William Bonello | Craig-Hallum Capital Group LLC |
| Matthew Sykes | Goldman Sachs |